Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 19 (HMGN1P19)

Target
HMGN1P19
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA), Other
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 19 (HMGN1P19) is a processed pseudogene located on human chromosome 7p12.3[4]. It is designated a pseudogene because it lacks known protein-coding function and is annotated as non-coding RNA[2]. No direct biological role has been characterized for HMGN1P19. By analogy to related high mobility group pseudogenes (such as HMGA1P6 and HMGA1P7), which can regulate expression of their parent genes and other cancer-associated genes via microRNA (miRNA) decoy activity, HMGN1P19 may have similar potential for gene regulation[1][3]. However, there is currently no evidence directly linking HMGN1P19 to biological pathways, diseases, pharmacology, or drug targeting. As such, HMGN1P19 is not recognized as a receptor, enzyme, transporter, or conventional therapeutic target. Its annotation as a pseudogene implies that structurally it shares sequence homology with the parent HMGN1 gene, but with key mutations that prevent translation into functional protein[2][4].

Other names
HMGN1P19
02

Biological functions

Possible regulation of gene expression through RNA-based mechanisms (e.g. competitive endogenous RNA, ceRNA, or miRNA decoy activity; this is inferred by analogy to other high mobility group pseudogenes such as HMGA1P6, HMGA1P7)
03

Disease associations

Other (no direct evidence for involvement in disease, but related pseudogenes show association with carcinogenesis by acting as miRNA decoys)

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 19 (HMGN1P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 19 (HMGN1P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call